Table 5. Staphylococcus aureus antimicrobial susceptibility with respect to age in patients with atopic dermatitis.
| Antibiotics | Lesional skin | Anterior nares | ||||
|---|---|---|---|---|---|---|
| ≤18 yr | >18 yr | p-value | ≤18 yr | >18 yr | p-value | |
| Clindamycin | 85 (85.9) | 67 (94.4) | 0.075 | 40 (88.9) | 31 (88.6) | 1.0 |
| Erythromycin | 70 (70.7) | 65 (91.5) | 0.001 | 27 (60.0) | 30 (85.7) | 0.012 |
| Habekacin | 99 (100.0) | 71 (100.0) | - | 45 (100.0) | 33 (94.3) | 0.188 |
| Oxacillin | 90 (90.9) | 67 (94.4) | 0.403 | 39 (86.7) | 34 (97.1) | 0.129 |
| Gentamicin | 86 (86.9) | 58 (81.7) | 0.355 | 38 (84.4) | 28 (80.0) | 0.604 |
| Penicillin | 17 (17.2) | 14 (19.7) | 0.672 | 6 (13.3) | 8 (22.9) | 0.266 |
| Bactrim | 99 (100.0) | 71 (100.0) | - | 45 (100.0) | 35 (100.0) | - |
| Vancomycin | 99 (100.0) | 71 (100.0) | - | 45 (100.0) | 35 (100.0) | - |
| Total | 99 (100.0) | 71 (100.0) | 45 (100.0) | 35 (100.0) | ||
| Ciprofloxacin | 57 (98.3) | 48 (100.0) | 1.0 | 7 (100.0) | 15 (93.8) | 1.0 |
| Fusidic acid | 38 (65.5) | 33 (68.8) | 0.725 | 4 (57.1) | 10 (62.5) | 1.0 |
| Rifampin | 58 (100.0) | 48 (100.0) | - | 7 (100.0) | 16 (100.0) | - |
| Teicoplanin | 58 (100.0) | 48 (100.0) | - | 7 (100.0) | 16 (100.0) | - |
| Tetracycline | 53 (91.4) | 45 (93.8) | 0.726 | 7 (100.0) | 16 (100.0) | - |
| Quinupristin/dafopristin | 58 (100.0) | 48 (100.0) | - | 7 (100.0) | 16 (100.0) | - |
| Nitrofurantoin | 57 (98.3) | 48 (100.0) | 1.0 | 7 (100.0) | 16 (100.0) | - |
| Linezolid | 58 (100.0) | 48 (100.0) | - | 7 (100.0) | 16 (100.0) | - |
| Telithromycin | 57 (98.3) | 48 (100.0) | 1.0 | 6 (85.7) | 16 (100.0) | 0.304 |
| Mupirocin | 55 (94.8) | 46 (95.8) | 1.0 | 6 (85.7) | 15 (93.8) | 0.526 |
| Tigecycline | 58 (100.0) | 48 (100.0) | - | 7 (100.0) | 16 (100.0) | - |
| Total | 58 (100.0) | 48 (100.0) | 7 (100.0) | 16 (100.0) | ||
Values are presented as number (%).